Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Menarini SA
Original Assignee
Laboratorios Menarini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Menarini SAfiledCriticalLaboratorios Menarini SA
Priority to ES553403ApriorityCriticalpatent/ES8705879A1/en
Publication of ES8705879A1publicationCriticalpatent/ES8705879A1/en
Publication of ES553403A0publicationCriticalpatent/ES553403A0/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
4-(7'-Benzofuryl)2,6-dimethyl 1,4-dihydro-pyridine 3,5-dicarboxylic acid esters of formula (I), for pharmaceutical use as hypotensive agents, are made by (a) reacting one equiv. of 7'-benzofuryl chloromethyl acetate of R1 with an equimolar amount of the beta-amino crotonate of R2 in non-alcoholic medium under reflux for 12-24 hours; (b) removing the solvent by rotary evapn.; and (c) re-crystallising from diethyl ether or solvent of similar polarity.
Salicylaldehyde and salicylic acid derivatives and their sulfur analogs, processes for their preparation and their use as herbicides and bioregulators.
Thiazolidinedione derivatives with antidiabetic, hypolipidemic and antihypertensive properties, processes for their preparation and pharmaceutical compositions containing them
Optically active N-alpha-fluoroacryloylamino acid derivatives, their preparation, their optically active polymers prepared and their use for cleavage of racemates
NEW 1- / 3- (2-DIALKYLAMINOAETHOXY) -2-THIENYL / -3-PHENYL-1-PROPANONE AND THEIR ACID ADDITION SALTS AND METHOD FOR THE PRODUCTION THEREOF AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.